← Back to headlines
Huons wins IND approval for Phase 2 dry eye drug trial
Huons, a South Korean pharmaceutical company specializing in ophthalmic and injectable medicines, said Thursday it has received Investigational New Drug approval from the Ministry of Food and Drug…
12 Mar, 03:57 — 12 Mar, 04:38
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center1
Center (1)
Korea Herald
Right
Far R
Geographic diversity— 2 regions9/34
US1South Korea1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
YahooMostly Factual43d ago
Pfizer’s Weight Management Drug Wins China Approval
Read full article →Korea HeraldMostly Factual43d ago
Huons wins IND approval for Phase 2 dry eye drug trial
Huons, a South Korean pharmaceutical company specializing in ophthalmic and injectable medicines, said Thursday it has received Investigational New Drug approval from the Ministry of Food and Drug Safety to begin a Phase 2 clinical trial of its dry eye treatment candidate. HUC1-394 is a peptide-based ophthalmic solution licensed from Novacell Technology. The drug selectively binds to Formyl Peptide Receptor 2 (FPR2) — a receptor involved in the body’s natural resolution of inflammation — activat
By The Korea Herald
Read full article →Coverage Timeline
First report: Korea Herald · 12 Mar, 03:57|Full coverage: 2 · 41m|Window: 41m
Left-leaningCenterRight-leaning
